UricNote Founding Offer
$9.99 $14.99 one-time · not a subscription
For the first 100 users only. You get the full Pro unlock forever — and your feedback shapes what gets built next. When the founding cohort closes, new users pay the standard price.
What Pro unlocks
- Doctor report — one A4 page your rheumatologist reads in a 15-minute visit: urate trend, flare history, adherence, meds
- Trigger ranking — what your last 3 flares had in common, from your own data (explainable rules, no black-box scores)
- Full trend analytics — dual-track view: medication adherence vs hydration vs pain-free days
What founding members get beyond the app
- Direct reply line — email the developer, he answers personally (he lives with high uric acid too)
- Roadmap votes — your suggestion, credited in the changelog when built
- Price locked forever — future features added to Pro will never bill you again
What UricNote is
A gout and uric-acid record keeper built on a treat-to-target review rhythm validated in clinical trials (GoutSMART, Lancet Rheumatology 2022). All data stays on your device. No account. No ads. No subscription — the founding unlock is one payment, done.
Why a founding price at all?
Because the first 100 users are not customers — they're co-designers. The discount buys honest feedback (especially the critical kind), and the changelog credits show exactly where suggestions became features.
UricNote is a record-keeping tool, not a medical device. In-app purchase through the Apple App Store. Sources: ACR 2020 Guideline; GoutSMART trial 2022; G-CAN 2024 remission criteria.